EKF Premiers Novel Point-of-Care Products at MEDICA
27 Nov 2013
Watch this video to see Julian Baines, Group CEO for EKF Diagnostics, discussing the novel products being showcased at MEDICA this year. In particular: the Quo-Lab and Quo-Test for HbA1c analysis; and the Hemo Control hemoglobin device (also sold as HemoPoint H2 in USA and Asia). Filmed by SelectScience at MEDICA 2013.
About the company
EKF Diagnostics
Empowering decision-making in point-of-care testing and life sciences applications.
EKF Diagnostics is a leading global diagnostics and biotechnology company specializing in the development, production, and distribution of innovative medical technologies and patient-centric solutions
We are committed to delivering high-quality, reliable, cost-effective tools that enable early detection, accurate diagnosis, therapeutic development, and effective condition monitoring.
Our products are designed to be cost-effective, providing accessible solutions to healthcare providers in diverse clinical settings, including hospitals, clinics, and laboratories.
EKF plays a critical role in the healthcare industry by offering high-quality, value-based diagnostic products. Our point-of-care testing devices allow healthcare professionals to perform rapid tests at the patient’s side, reducing the need for extensive lab testing and delivering quicker results. In addition, EKF is at the forefront of the life sciences sector, providing advanced tools that contribute to biotech development, research, and precision medicine.
